NeoGenomics Laboratories

NeoGenomics offers services for drug development programs and clinical trials.

NeoGenomics provides pharmaceutical companies with real-world multimodal oncology data solutions.

Paletrra is an AI-driven spatial proteomics solution that turns tissue into visual insights for clinical decision-making.

NeoGenomics says it works to improve access to oncology diagnostic tools intended to advance patient outcomes.

The company provides a resource library with updated resources.

The company provides transparency throughout the billing process.

NeoGenomics provides precision oncology diagnostics, pharma services, and information services.

Oncologist View is where oncology meets real-world practice. Authored by NeoGenomics experts and medical professionals, this blog shares diagnostic case studies, explores emerging trends in cancer testing, and delivers insights from the front lines of precision medicine.

NeoGenomics works with institutions and thought leaders to develop diagnostic, therapy selection, and MRD tests.

NeoGenomics' integrations team helps connect NeoGenomics with existing EHR, LIS, and LIMS systems for ordering and results delivery.

The company accepts inquiries and support requests by phone, fax, email, and online form.

NeoGenomics is a leader in precision oncology testing, empowering healthcare experts to optimize patient care.

The page describes how data is collected and protected for individuals residing in California.

The company added the recipient to its “Do not sell or share” list.

The page describes how data is collected and protected for individuals residing in the European Union.

NeoGenomics explains how it uses and discloses protected health information (PHI), its legal duties, and individuals' HIPAA rights and how to exercise them.

This Web site is operated by NeoGenomics Laboratories, Inc. and its subsidiaries and affiliates. View the Terms of Use for the NeoGenomics website.